C25-140

CAT: 0804-HY-120934-01Size: 1 mgDry Ice: NoHazardous: No
CAT#:0804-HY-120934-01Size:1 mg
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
C25-140, a first-in-class, orally active, and fairly selective TRAF6-Ubc13 inhibitor, directly binds to TRAF6, and blocks the interaction of TRAF6 with Ubc13. C25-140 lowers TRAF6 activity, reduces NF-κB activation, and combats autoimmunity[1].
CAS Number
[1358099-18-9]
UNSPSC
12352005
Hazard Statement
H302, H315, H319
Target
E1/E2/E3 Enzyme; TNF Receptor
Type
Reference compound
Related Pathways
Apoptosis; Metabolic Enzyme/Protease
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/c25-140.html
Purity
99.92
Solubility
DMSO : 41.67 mg/mL (ultrasonic)
Smiles
O=C(N1CCC(CC2=CC=CC=C2)CC1)CCC3=C(C)N(C4=NN5C(C=C4)=NN=C5C)N=C3C
Molecular Formula
C26H31N7O
Molecular Weight
457.57
Precautions
H302, H315, H319
References & Citations
[1]Brenke JK, et al. Targeting TRAF6 E3 ligase activity with a small-molecule inhibitor combats autoimmunity. J Biol Chem. 2018 Aug 24;293 (34) :13191-13203.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-P10835LAG-3 cyclic peptide inhibitor C25
HY-138946-01XY028-140
HY-170497EGFR-IN-140
HY-117966Bibn 140
HY-111082-01ISAM-140
HY-N15841C25 Ceramide (d18:1/25:0)
HY-100742A-01(R) -GNE-140
HY-179518Antifungal agent 140
HY-100742-01GNE-140 (racemate)
HY-100742B-01(S) -GNE-140

Alternative Products

CatalogName
7715/50C25-140
A18705-1C25-140 1mg
A18705-25C25-140 25mg
A18705-5C25-140 5mg
A18705-10C25-140 10mg
A18705-100C25-140 100mg
A18705-50C25-140 50mg
A18705-10mM-DC25-140 10mM * 1mL in DMSO
bs-60136C-01SKP2-C25 --- Skp2 Inhibitor
SMC-628SKv1.2 Antibody, Clone C25

Popular Products